AstraZeneca’s confusing vaccine data, biotech in 2021, and a guide to the ASH conference
Can too much Covid-19 vaccine be a bad thing? Is biotech in a bubble? And how do you make blind mice see again?
We discuss all that and more on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast. Georgetown virologist Angela Rasmussen joins us to break down AstraZeneca’s confusing Covid-19 vaccine data and what they might mean for the future of the pandemic. Then, longtime healthcare investor Adam Koppel calls in to offer some predictions for how 2021 will play out in biotech. Finally, we bring you a non-Covid lightning round, with the latest in hematology, a coup for AI in biology, and a breakthrough in aging research.
